NGUYEN, Phuong H.; RAMAMOORTHY, Ayyalusamy; SAHOO, Bikash R.; ZHENG, Jie; FALLER, Peter; STRAUB, John E.; DOMINGUEZ, Laura; SHEA, Joan-Emma; DOKHOLYAN, Nikolay V.; DE SIMONE, Alfonso; MA, Buyong; NUSSINOV, Ruth; NAJAFI, Saeed; NGO, Son Tung; LOQUET, Antoine; CHIRICOTTO, Mara; GANGULY, Pritam; MCCARTY, James; LI, Mai Suan; HALL, Carol; WANG, Yiming; MILLER, Yifat; MELCHIONNA, Simone; HABENSTEIN, Birgit; TIMR, Stepan; CHEN, Jiaxing; HNATH, Brianna; STRODEL, Birgit; KAYED, Rakez; LESNE, Sylvain; WEI, Guanghong; STERPONE, Fabio; DOIG, Andrew J.; DERREUMAUX, Philippe

doi:10.1021/acs.chemrev.0c01122

Metadatos

Mostrar el registro completo del ítem

Licencia de uso del documento

NGUYEN, Phuong H.

RAMAMOORTHY, Ayyalusamy

SAHOO, Bikash R.

Idioma

Article de revue

Este ítem está publicado en

Chemical Reviews. 2021, vol. 121, n° 4, p. 2545-2647

Resumen en inglés

Protein misfolding and aggregation is observed in many amyloidogenic diseases affecting either the central nervous system or a variety of peripheral tissues. Structural and dynamic characterization of all species along the pathways from monomers to fibrils is challenging by experimental and computational means because they involve intrinsically disordered proteins in most diseases. Yet understanding how amyloid species become toxic is the challenge in developing a treatment for these diseases. Here we review what computer, in vitro, in vivo, and pharmacological experiments tell us about the accumulation and deposition of the oligomers of the (A beta, tau), alpha-synuclein, IAPP, and superoxide dismutase 1 proteins, which have been the mainstream concept underlying Alzheimer's disease (AD), Parkinson's disease (PD), type II diabetes (T2D), and amyotrophic lateral sclerosis (ALS) research, respectively, for many years.< Leer menos

Palabras clave en inglés

Nanofibers

Peptides and proteins

Genetics

Aggregation

Crystal cleavage

Metadatos

Compartir este ítem

Licencia de uso del documento

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis

Idioma

Este ítem está publicado en

Resumen en inglés

Palabras clave en inglés

URI

DOI

Centros de investigación